CHO-K1/cyno BDCA2 Stable Cell Line

Recombinant CHO-K1 cells stably overexpress Macaca fascicularis C-type lectin domain family 4 member C (CLEC4C, BDCA2) on the surface. The surface expression of BDCA2 is validated by FACS analysis. This cell line is recommended for cell-based binding assay to screen antibodies against BDCA2 or to measure binding affinity between BDCA2 and anti-BDCA2 antibodies.

Price	$8500.00
Cat. No.	M00596
Size	2 vials Buy in bulk
Quantity
Est. Delivery


Ask us a question

Product Introduction Culture Conditions Bottom Notes

Product Introduction

Product Description	Recombinant CHO-K1 cells stably overexpress Macaca fascicularis C-type lectin domain family 4 member C (CLEC4C, BDCA2) on the surface. The surface expression of BDCA2 is validated by FACS analysis. This cell line is recommended for cell-based binding assay to screen antibodies against BDCA2 or to measure binding affinity between BDCA2 and anti-BDCA2 antibodies.
Culture Properties	Adherent
Stability	Stable through more than 16 passages without significant changes in assay performance or expression profile.
Size	Two vials of frozen cells (>1×10⁶ per vial in 1 mL).
Storage	Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received.

Back

Culture Conditions

Culture Medium	Ham’s F-12K (Kaighn’s), 10% FBS, 8 μg/ml Puromycin (Cat. No. A11138-03, Life Technologies)
Complete Growth Medium	Ham’s F-12K (Kaighn’s) (Cat. No. 21127-022, Life Technologies), 10% FBS (Cat. No. 10099-141, Life Technologies)
Freeze Medium-DATA	95% complete growth medium, 5% (V/V) DMSO (Cat. No. D2650, Sigma)

Back

Figure 1. FACS analysis of cell surface expression of cynomolgus BDCA2 on CHO-K1/cyno BDCA2 cells. The CHO-K1/cyno BDCA2 cells (blue) and the negative control CHO-K1 cells (red) were probed using PE-conjugated anti-human CD303 antibody (Cat. No. 130-090-511, Miltenyi Biotec). »

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.